This inventor holds 5 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignee: Life Technologies Corporation. Active years: 2017-2021.
Location History:
- Fremont, CA (US) (2017 - 2019)
- Half Moon Bay, CA (US) (2020 - 2021)
Company Filing History:
Years Active: 2017-2021
Title: Sylvia Chang: Innovator in Sequencing Technology
Introduction
Sylvia Chang is a prominent inventor based in Fremont, CA (US). She has made significant contributions to the field of sequencing technology, holding a total of 5 patents. Her work focuses on improving the quality and efficiency of sequencing processes, which are crucial in various scientific and medical applications.
Latest Patents
One of Sylvia's latest patents is titled "Systems and methods for run-time sequencing run quality monitoring." This invention provides systems and methods for monitoring the quality of sequencing runs in real-time. The system includes a processor that determines various types of run-time information related to the quality and progress of sequencing runs. It also features a user interface, such as a graphical user interface (GUI), that communicates important information to users regarding the quality of individual or multiple runs. Additionally, the system allows users to take actionable steps based on the information provided, such as terminating or repeating sequencing steps.
Another notable patent is "Methods and systems for variant detection." This method involves receiving electropherogram data from an instrument and analyzing it to identify mixed bases. The process includes validating these mixed bases and determining variants in the electropherogram data based on the validated information. This innovation enhances the accuracy of variant detection, which is essential for genetic research and diagnostics.
Career Highlights
Sylvia Chang has established herself as a key figure in the biotechnology industry. She works at Life Technologies Corporation, where she continues to develop innovative solutions in sequencing technology. Her expertise and dedication have led to advancements that benefit researchers and healthcare professionals alike.
Collaborations
Throughout her career, Sylvia has collaborated with talented individuals such as David Denny and Manjula Aliminati. These partnerships have fostered a creative environment that encourages the development of groundbreaking technologies.
Conclusion
Sylvia Chang's contributions to sequencing technology exemplify her commitment to innovation and excellence. Her patents not only advance scientific understanding but also enhance the capabilities of researchers in the field.